# Pediatric GVHD Low Risk Steroid Taper Trial

> **NCT05090384** · PHASE2 · COMPLETED · sponsor: **John Levine** · enrollment: 50 (actual)

## Conditions studied

- Acute Graft vs Host Disease
- Allogeneic Bone Marrow Transplantation
- Adverse Effects

## Interventions

- **DRUG:** Prednisone

## Key facts

- **NCT ID:** NCT05090384
- **Lead sponsor:** John Levine
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-10-20
- **Primary completion:** 2025-03-27
- **Final completion:** 2026-02-25
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2026-05-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05090384

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05090384, "Pediatric GVHD Low Risk Steroid Taper Trial". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT05090384. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*